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Studies on autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED)
and its mouse model – both caused by mutant AIRE – have greatly advanced the under-
standing of thymic processes that generate a self-tolerant T-cell repertoire. Much is now
known about the molecular mechanisms by which AIRE induces tissue-specific antigen
expression in thymic epithelium, and how this leads to negative selection of auto-reactive
thymocytes. However, we still do not understand the processes that lead to the activa-
tion of any infrequent naïve auto-reactive T-cells exported by AIRE-deficient thymi. Also,
the striking phenotypic differences between APECED and its mouse models have puz-
zled researchers for years. The aim of this review is to suggest explanations for some of
these unanswered questions, based on a fresh view of published experiments. We review
evidence that auto-reactive T-cells can be activated by the prolonged neonatal lymphope-
nia that naturally develops in young Aire-deficient mice due to delayed export of mature
thymocytes. Lymphopenia-induced proliferation (LIP) helps to fill the empty space; by favor-
ing auto-reactive T-cells, it also leads to lymphocyte infiltration in the same tissues as in
day 3 thymectomized animals. The LIP becomes uncontrolled when loss of Aire is com-
bined with defects in genes responsible for anergy induction and Treg responsiveness, or
in signaling from the T-cell receptor and homeostatic cytokines. In APECED patients, LIP
is much less likely to be involved in activation of naïve auto-reactive T-cells, as humans
are born with a more mature immune system than in neonatal mice. We suggest that
human AIRE-deficiency presents with different phenotypes because of additional precipi-
tating factors that compound the defective negative selection of potentially autoaggressive
tissue-specific thymocytes.
Keywords: AIRE, APECED, lymphopenia-induced proliferation, thymus, negative selection, autoantigens, immune
privilege, NOD
INTRODUCTION
The autoimmune regulator (AIRE) is a transcriptional activator
with a restricted expression pattern and important functions in
medullary thymic epithelial cells (mTECs) (1). The thymus is the
organ where a self-tolerant T-cell repertoire is established via pos-
itive and negative selection of thymocytes. To ensure tolerance
toward the set of tissue-specific antigens (TSAs) from different
peripheral organs, mTECs “promiscuously” express thousands of
TSAs that are then presented to developing thymocytes; one of
the best known among them is insulin (2, 3). AIRE is the best
characterized transcriptional regulator in mTECs. It is generally
accepted that its main thymic role is to ensure negative selection
of thymocytes with T-cell receptors (TCRs) with high affinities for
epitopes from TSAs. At first sight, this idea seems to fit with the
variety of endocrine, ectodermal, and lymphoid autoimmune dis-
eases that present in patients with AIRE mutations and comprise
the Autoimmune polyendocrinopathy candidiasis ectodermal dys-
trophy (APECED) or autoimmune polyendocrine syndrome type
I (APS-I) syndrome (4–6). However, there is curiously little dis-
cussion about how these infrequent naïve auto-reactive T-cells that
escape negative selection in AIRE-deficient thymi are activated to
cause disease in the periphery, or about the rather consistent early
onset of its highly unusual cardinal manifestations, or about the
strikingly different phenotypes in Aire−/−mice (7–9). Table 1 lists
the autoimmune features of AIRE-deficient humans vs. mice and
highlights their surprisingly limited overlap (7–21). Here, we pro-
pose the hypotheses that defective thymic negative selection is not
sufficient by itself to induce autoimmunity and that these differ-
ences in disease phenotypes reflect distinct varieties of additional
influences in Aire−/− mice vs. humans.
AIRE IS RESPONSIBLE FOR NEGATIVE SELECTION OF
TSA-SPECIFIC THYMOCYTES
The normal roles of Aire in TSA up-regulation by mTECs, and
thus in central tolerance induction, are firmly established. In mice
transgenic for single TCRs specific for immune-dominant epi-
topes from hen egg lysozyme (HEL) or ovalbumin (OVA), large
proportions of thymocytes are efficiently deleted if their neo-
self-antigens are expressed under Aire-dependent gene promoters.
Membrane-bound HEL or OVA (mHEL or mOVA) under the rat
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Table 1 | Phenotypes and autoantibodies differ betweenAPECED patients andAire−/− mice.
APECED patientsa Aire−/− miceb APECED patientsa Aire−/− miceb
DISEASES/IMMUNE CELL INFILTRATIONS AUTOANTIBODIESTO:
Chronic mucocutaneous candidiasis Type I IFNs
Hypoparathyroidism IL-22, IL-17F, IL-17A IL-17A (IL-17F) (11)
Addison’s disease NALP5
Ovarian failure Infertility CaSR
Testicular failure P450c17, P450c21, P450scc
Hypopituitarism IA-2, GAD65
Autoimmune hepatitis Liver infiltration TG, TPO
Intestinal dysfunction TDRD6
Pancreatitis AADC
Tubulointerstitial nephritis P450 1A2
Interstitial lung disease Lung infiltration TPH
Alopecia HDC
Vitiligo TH
Rash with fever SOX9/SOX10
Asplenia KCNRG
Keratoconjunctivitis Myelin protein zero (12)
Dental enamel dysplasia LPLUNC1 (13) Vomeromodulin (13)
Nail dystrophy BPIFB1 (14) BPIFB9 (14)
Type 1 diabetes OBP1a (16)
Hypothyroidism SVS2 (17)
CIPD (10) IRBP (15)
Pernicious anemia Gastritis alpha-fodrin (18)
Uveoretinitis TRP-1 (19)
Dacryoadenitis Mucin 6 (20)
Salivary gland infiltration
aAutoimmune phenotypes of APECED patients and their autoantibody reactivities are summarized from (21).
bSummarized from (9), only Aire−/− mice on C57BL/6 and BALBc backgrounds without additional immune defects are included.
CIDP, Chronic inflammatory demyelinating polyneuropathy; NALP5, NACHT leucine-rich-repeat protein 5; CaSR, calcium-sensing receptor; P450c17, steroid 17-α-
hydroxylase; P450c21, steroid 21-hydroxylase; P450scc, side chain cleavage enzyme; IA-2, islet antigen-2; GAD65, glutamic acid decarboxylase; TG, thyroglobulin;
TPO, thyroid peroxidase; TDRD6, tudor domain containing protein 6; AADC, aromatic l-amino acid decarboxylase; P450 1A2, cytochrome P450 1A2; TPH, tryp-
tophan hydroxylase; HDC, histidine decarboxylase; TH, tyrosine hydroxylase; KCNRG, potassium channel-regulating protein; BPIFB1, 1 bactericidal/permeability-
increasing fold-containing B1; OBP1a, odorant binding protein 1a; SVS2, seminal vesicle secretory protein 2; IRBP, interphotoreceptor retinoid-binding protein;TRP-1,
tyrosinase-related protein-1; LPLUNC1, Long palate lung nasal epithelium clone.
Shared autoimmune features are indicated in bold.
insulin promoter (RIP) is expressed in both pancreatic β cells
and the thymus (22, 23), and mHEL under the interphotorecep-
tor retinoid-binding protein (IRBP) promoter in both retina and
thymus (24). When these mice are crossed with the respective TCR-
transgenic animals, their clonotypic thymocytes are deleted with
75–97% efficiency, but only in mice with intact Aire, highlighting
its indispensable role in negative selection. Moreover, the preva-
lence of neo-self-antigen-reactive T-cells is reduced still further
in the periphery, underlining the importance of active peripheral
tolerance mechanisms.
Interestingly, expression levels of the transgenes in the thymus
varied in different studies. In a retinal neo-self-antigen model, the
transgenic mRNA (Escherichia coli β-galactosidase under arrestin
promoter) was undetectable even in the wild-type (wt) thymus
(25). Whereas mHEL showed the expected Aire-dependent pattern
of higher expression in wt than Aire−/− mTECs (24, 26) (when
driven by the insulin or IRBP promoters), transcript levels for RIP-
driven mOVA were not markedly decreased in Aire−/− thymi (22).
This raises the possibility that, besides up-regulation of TSAs in the
thymus Aire plays additional roles in generating self-tolerance, e.g.,
inducing the maturation of mTECs, as reviewed recently (27, 28).
Loss of Aire also alters thymic architecture and mTEC ultrastruc-
ture (29, 30), and these effects reach back even to the immature
Aire-negative mTEC subset (31). Indeed, there are reports that
Aire-deficiency leads to breakdown of tolerance even to appar-
ently Aire-independent antigens (18). Moreover, the development
of the most mature single CD4 positive thymocyte subpopulation
(CD69−, Qa-2+) is impaired in Aire-deficient thymi (32).
The role of Aire in negative selection has also been studied
in TCR-transgenic models where clonotypic T-cells are targeted
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toward naturally expressed self-antigens such as the melanocyte-
/melanoma-specific tyrosinase-related protein-1 (TRP-1). In these
mice (on a Rag−/− background), negative selection again
depended on Aire; when its only change was the dominant negative
Aire G228W point mutation, melanoma growth was decreased.
Surprisingly, however, vitiligo was not reported in this study,
although TRP-1 is also expressed in normal melanocytes (19).
The role of Aire in negative selection has also been studied in
another TCR-transgenic model with reactivity to the major retinal
autoantigen – IRBP. Although its thymic expression is reportedly
Aire-dependent, clonotypic thymocytes were not deleted in any of
three transgenic mouse lines on the uveitis-susceptible B10.RIII
background (33). On the contrary, in two of them, the majority
of CD4 single positive thymic T-cells bound IRBP–MHC dimers;
strikingly they were several-fold more frequent than in wt animals
(33). Uveitis developed spontaneously in these two mouse lines,
but not in the third, where frequencies were lowest in both thymus
and periphery: 6 and 1% respectively; those were still much higher
than in Aire−/− mice with no TCR-transgene (34). Clonotypic T-
cell deletion was also incomplete in mice transgenic for an insulin
B chain epitope-specific TCR, only a fraction of which developed
diabetes (35).
Several studies have confirmed the importance of thymic nega-
tive selection of auto-reactive T-cells in physiological settings, i.e.,
in mice with un-manipulated T-cell repertoires (34, 36). Indeed,
thymic stromal or lymphoid cells were necessary to confer toler-
ance to the central nervous system (CNS) antigen myelin prote-
olipid protein (PLP) (36). Importantly, susceptibility to experi-
mental autoimmune encephalomyelitis (EAE) in SJL/J mice could
be explained by the exclusion of the immunodominant epitope
of PLP (for this strain) from the thymic isoform of PLP, and
the export of potentially auto-reactive cells to the periphery (36).
However, this model of EAE in SJL/J mice does not develop spon-
taneously, but requires immunization with antigen emulsified in
complete Freund’s adjuvant (CFA).
NAÏVE AUTO-REACTIVE T-CELLS DO NOT CAUSE
AUTOIMMUNITY BY DEFAULT
According to current models, AIRE’s main role is to ensure nega-
tive selection of TSA-specific thymocytes. If so, self-reactive T-cells
escaping from Aire−/− thymi must normally be naïve and infre-
quent. Even when frequencies are much higher in TCR-transgenic
models, disease penetrance is not always 100%, especially when
the TCRs are expressed in CD4+ T-cells. In the TCR–TrpHEL
model, with neoantigen expression in melanocytes, 12% of the
animals remained free of vitiligo (37); in an RIP–OVA OTII model
with neo-self-antigen expression in pancreatic β-cells, about 1/3
were persistently non-diabetic (23) in spite of large numbers of
auto-reactive T-cells in the periphery. TSA-specific T-cells are
much less frequent in Aire−/− animals with un-manipulated T-
cell repertoires. How their uncommon naïve thymic emigrants are
activated to induce autoimmune disease in the periphery remains
unexplained, one might expect them to get tolerized instead (38,
39). Indeed, when naïve T-cells encounter self-antigen in tissue-
draining lymph nodes or spleen in wt mice, they undergo an initial
burst of proliferation that is followed by deletion and anergy (40–
44) or acquisition of regulatory T-cell (Treg) phenotypes (35, 45).
In intriguing contrast, autoimmunity readily develops when naïve
auto-reactive T-cells are transferred to lymphopenic hosts (46, 47).
LYMPHOPENIA TRIGGERS AUTOIMMUNITY IN AIRE−/− MICE
The striking similarities in manifestations in Aire−/− and day 3
thymectomized mice (d3tx) have been noticed earlier (48–50).
Both models show inflammatory infiltrates in similar tissues plus
autoantibodies against some of their antigens in: stomach, thyroid,
ovaries, prostate, pancreas, lacrimal and salivary glands, and testis
(9, 18, 50–55). With both types of models, the manifestations even
follow the same strain-specific preferences: e.g., generally lower
autoimmune susceptibility in C57BL/6 mice, whereas gastritis is
the most prevalent feature on the BALBc background.
In d3tx mice, the autoimmunity is explained by prolonged
lymphopenia-induced proliferation (LIP) of auto-reactive lym-
phocytes that out-compete Tregs in susceptible animals (56, 57).
Although normal neonatal mice show a physiologic lymphope-
nia, it does not induce substantial LIP (56). We have shown that,
besides inducing TSA expression, thymic Aire normally upreg-
ulates several chemokines, especially CCR7 and CCR4 ligands,
that attract immature thymocytes to the medulla. Their cortico-
medullary migration is delayed in Aire−/− mice, and that, in turn,
delays the export of their mature progeny, prolonging the post-
natal lymphopenia at least through day 5 (31). Interestingly, mice
deficient in CCR7 (or its ligands) show not only similar delays in T-
cell emigration from the thymus but also inflammatory infiltrates
in the very organs listed above (58–60). We therefore hypothe-
size that LIP also contributes to these inflammatory infiltrates and
compensates for the relatively low numbers of naïve auto-reactive
T-cells that escape from Aire−/− thymi. This notion is supported
by the evidence that the lymphopenia in irradiated Aire−/− mice
increases the gastric autoimmunity (20); and that Aire expression
is required only in the fetal and early post-natal periods to prevent
autoimmunity (48).
Lymphopenia-induced proliferation is sometimes classified
according to the rate of division of T-cells to homeostatic and
spontaneous proliferation (56). It is highest when chronically
lymphopenic adult mice are reconstituted with low numbers of
lymphocytes (56, 61). In this case, T-cells respond to antigens
derived from commensals, which probably translocate from the
gut to lymphoid organs due to the host immunodeficiency (61).
Commensals seem unlikely contributors to the LIP that occurs
early in life, e.g., in d3tx mice. Nevertheless, LIP favors auto-
reactive cells, as they get stronger signals through their TCRs
as well as from homeostatic cytokines (IL-7 and IL-15) that are
upregulated in lymphopenic hosts. As they concomitantly differ-
entiate, these T-cells acquire the markers of activated memory cells
(CD44+CD62L−) (62–66).
There are several indications of homeostatically proliferating
T-cells in Aire−/− mice, including signs of oligoclonality (67).
Whereas thymocytes from Aire-deficient and wt mice showed no
differences in TCR Vβ-chain CDR3 length and spectratype, splenic
T-cells from Aire−/− mice showed a clear alteration in the TCR
repertoire distribution in 3 out of 24 Vβ families at 2 and 6 months
of age (67). A more recent study also found slight perturbations in
CDR3 Vβ length distribution, and significantly higher percentages
of CD44+ T helper cells in spleens and lymph nodes of Aire−/−
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mice than in wt controls (9). CD44 up-regulation in T-cells from
Aire−/− mice was also noted by Anderson et al. (68).
Looking for further activation of auto-reactive cells in lym-
phopenic conditions, Kekalainen et al. (69) transferred lymph
node cells from Aire+ and Aire−/−mice to immunodeficient hosts.
However, although especially the CD8+ Aire−/− T-cells prolifer-
ated more, there was no clinical disease, and the mild infiltrates
in the livers, salivary glands, and pancreata did not differ from
those in the controls. The rare auto-reactive cells in these animals
had probably already been tolerized by peripheral mechanisms in
the donors themselves. This suggests that prolonged lymphope-
nia in the neonatal period, together with export of naïve cells to
the periphery, contributes substantially (but not exclusively) to the
development of inflammatory infiltrates in Aire−/−mice, and that
the auto-reactive cells are subject to regulation in the periphery
that prevents serious damage to the target organs.
Certain TCR-transgenic T-cells are also prone to homeosta-
tic proliferation. These include the MHC-class I-restricted OT-I
line recognizing a peptide from OVA (62). Interestingly, sponta-
neous diabetes already appears in neonatal RIP–OVA Aire−/−OT-I
mice (22). This severe autoimmunity might well have been poten-
tiated by perinatal activation of the transgenic T-cells in these
lymphopenic hosts.
AIRE AND LIP IN AUTOIMMUNITY AGAINST PRIVILEGED
ORGANS
Autoantigens from some organs like the CNS/retina were thought
to be sequestered from the immune system, which might there-
fore not be fully tolerant to them. It has been suggested that AIRE
might play especially important roles in protecting these organs
from autoimmune attack, e.g., provoked by local infections (49).
Indeed, central deletion of auto-reactive thymocytes would be a
particular priority for CNS and eye antigens, as regeneration is
minimal in these tissues, and their peripheral tolerizing mech-
anisms might be inefficient. The intraocular compartments are
isolated from the circulation – by barriers formed by tight junc-
tions between the endothelial cells of the ciliary blood vessels,
and between the lining epithelial cells; also in the retinal pigment
epithelium (RPE) and the local endothelium (70–72). These bar-
riers are impermeable to circulating soluble macromolecules and
most cell types except for activated T-cells and immature antigen-
presenting cells (APCs). In the other direction, any soluble retinal
antigens (such as IRBP) shed physiologically or injected exper-
imentally can drain via the aqueous fluid and episcleral veins to
reach the thymus, liver, and spleen (70). The resulting systemic tol-
erance is termed anterior chamber-associated immune deviation
(ACAID). The presumed privilege of the eye used to be attributed
to paucity of APCs and lymphatics, but it is now known that there
are rich networks of APCs and a functioning lymphatic system
draining all parts of the eye, except the retina proper, via the sub-
mandibular node (70–72). Thus, ocular privilege is not due to a
passive barrier, but instead depends on inducible active processes
that can be transferred by immune cells.
One prominent feature in Aire−/− mice is their retinal disease.
Although it is extremely rare in APECED patients who frequently
suffer from keratito conjunctivitis (4, 73), it affects ~30% of these
mice by age 20 weeks on a C57BL/6 background (34). Recently,
they were backcrossed onto the autoimmune uveitis-susceptible
B10.RIII background to monitor eye pathology more carefully
(74). Surprisingly, the spontaneous disease was milder on the
Aire−/− background than in the other two models (induced by
immunization with IRBP+CFA or arising spontaneously in IRBP
TCR-transgenic mice), and rarely caused blindness. Instead, it pre-
sented with relatively low-grade but multi-focal retinal inflamma-
tion and severe choroiditis, possibly hinting at moderately potent
regulatory mechanisms.
There are many indications that EAU is enhanced by LIP of self-
reactive T-cells (33,75,76). In intact wt recipients, IRBP-transgenic
T-cells only induced uveitis after antigen-activation: recipients
of naïve cells, even from the highest transgenic TCR-expressing
line, remained disease-free. In telling contrast, naïve T-cells did
induce disease when transferred to lymphopenic Rag2−/− recipi-
ents, again implicating LIP in converting them into effector cells
(33). In the same study, LIP was evidenced in the mouse lines
with higher prevalences of TCR-transgenic T-cells by increases in
CD44+CD62L− activated T-cells, even in peripheral lymph nodes
that do not drain the eye. This implicates LIP in these transgenic
animals too, possibly due to aberrant thymic development, and
probably lymphopenic periods earlier in life (33). LIP has also
been identified as a potent activator of EAU in another transgenic
model (76) and, interestingly, uveoretinitis develops in unimmu-
nized d3tx mice if subsequently injected with anti-CD25 to deplete
CD25+CD4+ Tregs (75).
REVERSAL OF LYMPHOPENIA ALLEVIATES AUTOIMMUNITY
Autoimmunity that results from LIP should be down-modulated
by transfer of lymphocytes. This indeed occurs in Aire−/− mice,
where the appearance of inflammatory infiltrates could be sup-
pressed by introducing a controlled excess of T-cells from normal
donors – by co-transplanting 1:4 mixes either of Aire−/−: wt
stroma from thymic lobes, or of splenocytes, into athymic or
Rag−/−recipients, respectively (22).
As the phenotypes of Aire−/− mice are so mild, it is difficult to
dissect the mechanisms that might be modulating their autoim-
munity. Therefore, crosses of Aire−/− with NOD mice have been
used, as they develop earlier and more severe autoimmunity (48).
In these crosses, Aire expression is especially important during
perinatal life. Moreover, intraperitoneal injection of adult T-cells
on days 1 and 7 conferred significant but not complete protection
from this exaggerated autoimmunity (48) (see below).
IS ABSENCE OF SELF-ANTIGEN FROM THE THYMUS
SUFFICIENT BY ITSELF TO INDUCE ORGAN-SPECIFIC
AUTOIMMUNE DISEASE?
It is sometimes assumed that the autoimmunity results solely from
the absence of a single autoantigen from the thymus in the presence
of wt Aire. That is apparently contradicted by our hypothesis that
prolonged lymphopenia in Aire−/− mice is an important cofactor
for auto-aggression, so we now discuss two models that might help
to distinguish between these possibilities.
DeVoss et al. identified IRBP as the major target in autoim-
mune uveitis in Aire−/− mice (15). Its thymic expression is Aire-
dependent, although it is barely detectable in wt thymic stroma.
Absence of IRBP in the thymic compartment alone was sufficient
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to cause disease when athymic nude mice were transplanted with
fetal thymic stroma from IRBP−/− mice or wt mice. Mononu-
clear infiltrates appeared in their retinae, but not in recipients of
wt stroma. Here again, lymphopenia must have been an impor-
tant early contributor, as the first thymic emigrants appeared to
abnormal lymphopenic adults.
When DeVoss et al. also crossed Aire−/− with IRBP−/− mice,
the retinae showed no infiltrates, as expected because there was
no target for the IRBP-specific cells to attack. However, IRBP is
secreted, and even reaches the vitreous, and eventually drains to
the spleen and lymph nodes (77). Hence this major eye retinal
autoantigen was missing from the peripheral immune system too,
and was not available to fuel homeostatic proliferation of IRBP-
specific T-cells. Also the IRBP−/− retina is atrophic and might be
depleted of other autoantigens.
Interestingly, when mice transgenic for mHEL under the IRBP
promoter were crossed with HEL-specific TCR-transgenic mice,
they showed severe spontaneous EAU even on a wt Aire back-
ground (24). Negative selection of clonotypic T-cells was not
complete in this model, and many neo-self-antigen-specific T-
cells were exported to the periphery. The mHEL – unlike soluble
IRBP itself – may have failed to access lymphoid organs/induce
peripheral tolerance. The resulting disease was already so severe
that any exacerbating effect of Aire-deficiency was not detectable.
If these HEL-specific clonotypic T-cells were susceptible to LIP
due to cross-reactivity with some self epitopes (which has not
been checked), that might well have contributed too.
In another study, mice were engineered specifically to prevent
any insulin expression in mTECs, and to use only one of the two
insulin genes (Ins2) in their pancreatic β-cells (78). They devel-
oped spontaneous diabetes within 3 weeks after birth. However,
there are also some caveats with this study (79). The diabetes
was not transferrable to immunodeficient adult hosts with lym-
phocytes or thymi from the transgenic mice, which showed only
moderate insulitis (80). This apparently implicates the additionally
impaired physiology of Ins1−/− β-cells (compensatory hyperpla-
sia, increased death during the developmental wave of apoptosis
that occurs in normal development) in disease initiation in very
young mice (81). In this model again, loss of thymic negative selec-
tion alone was not sufficient to cause clinical disease. Furthermore,
since insulin is already secreted in the fetus, it should normally be
available for thymic deletion, e.g., when presented by medullary
dendritic cells, without promiscuous expression in mTECs, but its
levels may be decreased prenatally in Ins1−/− mice, reducing its
availability for negative selection.
AIRE-DEFICIENCY BECOMES LETHAL IF PERIPHERAL
BACK-UP MECHANISMS ARE ELIMINATED
Two highly informative crosses of Aire−/− mice – with strains
with other immune defects – underline the importance of back-
up mechanisms that are apparently responsible for the mildness
of the disease phenotypes in Aire−/− mice. Crosses onto Cbl-b-
deficient or diabetes-prone NOD backgrounds show astonishing
similarities (39, 53, 82). They both suffer from early wasting disease
and succumb to acute exocrine pancreatitis around 3–4 weeks of
age. Aire−/−/Cbl-b−/− mice showed additional lymphocytic infil-
trates in submandibular salivary glands and stomach (39), while
Aire-deficiency on the NOD background was accompanied by
severe pulmonitis and infiltrates in liver, salivary gland, prostate,
ovary, stomach, and thyroid (53, 82).
Interestingly, mice deficient in Cbl-b alone are healthy in the
absence of additional triggers (83), so it was a major surprise that
crossing with Aire−/− mice led to such severe disease. Cbl-b nor-
mally renders naïve T-cells highly dependent on co-stimulation;
when it is deleted, they are “trigger-happy,” and much less sus-
ceptible to anergy. Clonal deletion of CD8+ T-cells also depends
on Cbl-b, and Cbl-b-deficient T-cells are partially resistant to
Treg cell-mediated suppression (83). Furthermore, induction of
Tregs from naïve precursors is likewise impaired in the absence of
Cbl-b (84).
The CD44+ memory phenotype T-cells generated by LIP are
normally restrained by Tregs that proliferate rapidly in d3tx mice
and are crucial for preventing autoimmunity in lymphopenic
animals (50, 85). In Aire−/−/Cbl-b−/− mice, readier activation
of homeostatically proliferating T-cells, impaired induction of
peripheral Tregs and lower responsiveness of proliferating lym-
phocytes to the influence of Tregs are probably responsible for
their severe early autoimmunity. The proportions of CD4+ and
CD8+ T-cells with CD44high were greatly increased in these
double knock-outs. This supports the idea that LIP is partici-
pating during prolonged lymphopenia in Aire−/− mice, where
“trigger-happy” polyclonal T-cells proliferate in response to avail-
able self-peptide-MHC complexes in the presence of homeostatic
cytokines.
Interestingly, the immune defects in NOD mice include mild
lymphopenia and dysregulated function of homeostatic cytokines
(46). Indeed, T-cell transfer and CFA injection protect NOD mice
against diabetes (46). The efficiency of their thymic selection has
been a matter of controversy; recent data are in line with normal
negative selection but impaired positive selection in NOD mice
due to selective defects in the Erk1/2 signaling module down-
stream of TCR (86) that is important for T-cell survival and
tuning of TCR responsiveness. In the periphery, anergy induction
appears normal in NOD T-cells. Insulin-specific effector T-cells
were generated in pancreatic lymph nodes only between 3 and
5 weeks of age, at the time of increased release of β-cell anti-
gens (87). In all mouse strains, a wave of β-cell apoptosis occurs
during the neonatal period, peaking at 9–15 days, but apoptotic
debris is cleared less efficiently in NOD mice (88). Interestingly,
diabetes is accelerated in mice thymectomized at week 3 – i.e.,
precisely when β-cell-specific T-cells are initially activated – when
Tx caused moderate lymphopenia. Furthermore, the timing of
that lymphopenia is evidently critical in target organ selection;
while d3tx in NOD mice did not affect diabetes incidence, gas-
tritis became much commoner (88). Indeed, this Aire−/−/NOD
combination may maximize homeostatic proliferation just when
exocrine pancreatic antigen release is greatest. The combination
of impaired positive selection in NOD mice with delayed migra-
tion of thymocytes into the Aire−/− medulla apparently ampli-
fies the neonatal lymphopenia, which is further exaggerated by
hyper-responsiveness of NOD T-cells to IL-21 and poor T-cell sur-
vival. Homeostatically proliferating cells compete for IL-7 and/or
available MHC/(cross-reactive) self peptides (56). Therefore the
absence of diabetes in Aire−/−/NOD mice may implicate the early
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proliferation of T-cells that encounter other available autoantigens
and fill the space before the β-cell antigens are released.
Why the autoimmune attack focuses on the exocrine pancreas
remains obscure. We suggest that three peculiarities of neona-
tal mice might be relevant: (1) readier access of neonatal T-cells
to peripheral organs (89) where they normally differentiate into
TSA-specific Tregs (45). Interestingly, this conversion to Tregs is
subverted by IL-7 (45); (2) rapid changes and increased blood
flow to certain organs (lungs, pancreas, liver, and intestine) after
birth that renders their antigens more accessible to T-cells; (3)
autophagy that is naturally upregulated immediately after birth –
to adapt to the loss of the constant trans-placental supply of nutri-
ents – especially in muscle/diaphragm, heart and lungs; also the
pancreas, which undergoes major changes after birth too, to meet
the demands for the proteolytic enzymes it must now secrete (90).
Their premature intracellular activation in autophagolysosomes,
together with autoimmune attack by “trigger-happy” homeostati-
cally proliferating T-cells, might greatly exacerbate the tissue dam-
age. The thymic involution in Aire−/−/Cbl-b−/− mice could be
the result of stress or a “cytokine storm” created by this fulminant
pancreatic disease.
TREG CELLS IN AIRE-DEFICIENCY
Studies in APECED patients have shown significantly lower Treg
numbers and function than in healthy controls (91–94). Whether
this is a direct effect of the thymic AIRE-deficiency or secondary
to the severe autoimmune diseases in these patients remains
unknown. By contrast, the role of Aire-deficiency in the devel-
opment of Treg cells in the mouse thymus is controversial. Many
studies have reported that their numbers are unchanged (9, 18, 26,
95), but others have found them reduced (22, 96, 97). In peripheral
organs, their numbers and function are similar to those in wt mice
(9, 22). Recently, Malchow et al. showed appearance of Tregs spe-
cific for an Aire-dependent TSA that proliferated in tumors and
could therefore interfere in their rejection (96). The autoimmunity
in d3tx mice was initially thought to arise because of significantly
later maturation and release of Tregs than of effector cells (55).
However, Tregs proliferate equally well in d3tx lymphopenic hosts,
which is important in the prevention of autoimmunity (50, 64).
Interestingly, LIP is even greater in Tregs from Aire−/− than wt
mice when transferred to lymphopenic hosts (69).
One of the crosses that showed no additive effect on the phe-
notype of Aire−/− mice was with Card11unm/unm (39). Normally,
Card11 acts in the NFκB module of TCR-signaling, and this
mutation leads to impaired Foxp3+ Treg differentiation in the
thymus, 6–7 times fewer peripheral Tregs, and a gradual increase
in Th2 cells (98). Interestingly, however, in Aire−/− mice, these
low-frequency Tregs could still reduce tissue infiltration. Further-
more, while Tregs are crucial for controlling autoimmunity against
several organs, they seem to play no prominent role in eye disease:
FoxP3-mutant scurfy mice do not develop spontaneous uveitis,
suggesting that other tolerance mechanisms are more important
than Tregs in protecting against retinal autoimmunity.
Also very informative are the crosses of B6.Foxp3sf mice (with
the null “scurfy” Foxp3 gene mutation) onto the Aire−/− mice
or NOD genetic backgrounds (99). The Sf mutation by itself
causes characteristic skin disease, massive lymphoproliferation,
and infiltration most severely in the liver, but also the lungs and
exocrine pancreas (100, 101). The crosses onto both backgrounds
started to develop more severe lung and liver infiltrates much
earlier and died significantly younger than B6.Foxp3sf mice (99).
While there were no changes in the infiltrates characteristically
seen in other organs in B6.Foxp3sf mice, those typical of Aire−/−
mice on the C57BL/6 background (in the eyes, salivary glands)
were – surprisingly – not seen in the B6.Foxp3sf Aire-deficient mice.
Moreover, phenotypes were identical in sf mutant mice on these
Aire−/− and NOD backgrounds; to us, that implicates prolonged
neonatal LIP rather than deficiency in thymic negative selection
in this aggravated pathology in both crosses. Sf mutant Tregs are
evidently not able to limit the activation of homeostatically pro-
liferating T-cells. This is also illustrated by the similar wasting
disease (with infiltrates in lungs, liver, pancreas, and stomach) in
a model where neonatal T-cells are unable to respond to TGF-β
signaling (102).
WHAT IS TRIGGERING AUTOIMMUNITY IN APECED
PATIENTS?
If the mild phenotypes in Aire−/−mice are in line with the require-
ments for pathogenic T-cell activation, why are the phenotypes
so much more severe in APECED patients? In humans too, it
seems very unlikely that defective negative selection is the only
cause of the severe autoimmune destruction of endocrine glands
and other tissues (6, 21, 103). We are born with a much more
mature immune system than mice (104, 105). Although lym-
phocyte function is under-developed in neonates, their numbers
per milliliters of blood are even higher than in adult humans.
Therefore, even if thymocyte migration is delayed because of
impaired chemokine secretion by AIRE-deficient mTECs in the
human fetus, this is probably compensated by the longer gestation.
Neonatal lymphopenia has not been studied in APECED because
the disease is usually diagnosed much later. Interestingly though,
adult APECED patients have increased IL-7 concentrations in their
sera that may be related to impaired T-cell homeostasis (106).
The clear differences in disease phenotypes between APECED
patients and Aire−/− mice suggest separate precipitating factor(s)
in humans. These remain unidentified, but the surprisingly simi-
lar autoantibodies in patients with APECED and thymoma make
any contribution from lymphopenia in human AIRE-deficiency
seem even less likely (107). Nevertheless, the same logic – that
additional activation is required before the rare naïve auto-reactive
cells that escape from human AIRE-deficient thymi/thymomas can
induce autoimmune disease – must apply in humans too (6, 103).
In APECED, CMC, hypoparathyroidism, and Addison’s disease
sometimes present even at 2–3 years of age (4). Evidently, T-cells
must go onto attack very soon after birth to destroy sufficient tis-
sue to cause disease so soon; to us, that argues against any need for
environmental triggers. Moreover, the first targets of the autoim-
mune attack are not AIRE-dependent TSAs (21). We propose that
the pathogenic T-cells are already primed before their export from
AIRE-deficient thymi or thymomas. A study on T-cells in APECED
adults has shown gross alterations, especially in the CD8+ pop-
ulation, that include increased proliferation, lower expression of
both IL-7R and the negative regulator of TCR-signaling CD5, and
also absence of the regular naïve T-cell compartment, relative to
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age-matched healthy controls (106). That could be secondary to
the autoimmune diseases in APECED, a possibility that could be
tested by assessing the activation of recent thymic emigrants before
onset of APECED in pre-symptomatic young siblings of known
patients.
In APECED, autoantibodies neutralizing type I IFNs and IL-22
can reach high titers even by 7 months of age, when autoantibodies
to steroidogenic enzymes may also start to appear (108). Moreover,
these autoantigens are produced in the thymus by cell types other
than mTECs, so they should be available for negative selection
even when AIRE is deficient (103). To explain these peculiarities,
we have suggested biased selection or active autoimmunization
in human thymi rendered “dangerous” by AIRE-deficiency (21,
103). That even leads to other secondary lymphoid tissue behav-
ior in thymomas such as spontaneous production of anti-IFN-α
and IL-12 autoantibodies by terminal plasma cells in sero-positive
patients (109).
FURTHER PREDICTIONS
If gastritis in BALBc mice and EAU in B10.RIII mice are caused by
LIP, they should be ameliorated by blocking homeostatic cytokines
postnatally and simultaneously transferring lymphocytes into the
lymphopenic hosts. As these cytokines sensitize TCRs through
induction of pERK1/2, its inhibitors could be tested instead (65).
The phenotype of Cbl-b- and Aire double deficient mice
could be mimicked by crossing with other mutant mouse strains
with impaired T-cell susceptibility to anergy induction, or by
thymectomizing Cbl-b−/− mice on days 1–3.
Curiously, autoimmunity is more often related to lower than
higher TCR-signaling, perhaps because of weaker peripheral tol-
erance (65, 86). During their development, cortical thymocytes
are positively selected when their receptors are triggered by self-
peptide-MHC complexes. These so called “tonic” signals are also
needed for T-cell survival in the periphery, but they are regulated
to remain just below the threshold for activation and proliferation
(62). When TCR-signaling is impaired, the cells have to adapt to
respond to weaker signals, which makes them more responsive to
self-antigens, e.g., during periods of over-production of homeo-
static cytokines. Theoretically, crosses of Aire−/− mice onto back-
grounds with decreased TCR-signaling and reduced T-cell survival
could lead to phenotypes similar to those in Aire−/−×NOD
crosses.
SUMMARY
It is unlikely that defective negative selection of auto-reactive
thymocytes in AIRE-deficient thymi is the only cause of the asso-
ciated autoimmune diseases in either model mice or APECED
patients. Naïve T-cells require activation before they can cause tis-
sue destruction: in uninfected neonates with no danger signals,
tolerization by peripheral mechanisms seems a much likelier out-
come. A hitherto under-recognized feature of Aire−/−mice is their
prolonged neonatal lymphopenia: by inducing LIP, it favors the
proliferation and activation particularly of auto-reactive T-cells.
This also helps to explain the strikingly similar phenotypes of
lymphopenic day 3 thymectomized and Aire−/− mice. However,
the many developmental (ontogenetic) differences make LIP seem
a much less likely contributor in humans – where we propose
that additional mechanisms promote the early and much more
sharply focused autoimmune attack on such unusual targets as
the parathyroids, steroidogenic tissues/enzymes, and cytokines.
The mouse model has been extremely valuable in demonstrat-
ing Aire’s role in negative selection of auto-reactive thymocytes.
However, the differences in pathogenetic mechanisms and in
autoimmune phenotypes in APECED patients question its suit-
ability for testing new treatment options, and imply that merely
restoring thymic TSA expression might not be enough to halt the
autoimmunity in the patients. They also emphasize the impor-
tance of studies in human subjects, and again underline the need
for caution when extrapolating from mouse models.
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